AbbVie Inc.
Astellas Pharma Inc.
AstraZeneca
Bristol Myers Squibb
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline
Johnson & Johnson
Merck & Co.
Novartis
Pfizer Inc.
Sanofi
Published | Pages | Publisher | Report code |
---|---|---|---|
Aug 2024 | 194 | Diligence Insights | ASDR-667493 |
AbbVie Inc.
Astellas Pharma Inc.
AstraZeneca
Bristol Myers Squibb
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline
Johnson & Johnson
Merck & Co.
Novartis
Pfizer Inc.
Sanofi